Ubs Group Ag Neurosense Therapeutics LTD Wt Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

A detailed history of Ubs Group Ag transactions in Neurosense Therapeutics LTD Wt stock. As of the latest transaction made, Ubs Group Ag holds 605 shares of NRSNW stock, worth $108. This represents 0.0% of its overall portfolio holdings.

Number of Shares
605
Holding current value
$108
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$0.1 - $0.5 $60 - $302
605 New
605 $0
Q3 2023

Nov 09, 2023
BUY
$0.11 - $0.28 $418 - $1,064
3,802 New
3,802 $0
Q4 2022

Feb 08, 2023
SELL
$0.16 - $0.44 $185 - $510
-1,160 Reduced 59.24%
798 $0
Q3 2022

Nov 10, 2022
BUY
$0.19 - $0.4 $372 - $783
1,958 New
1,958 $0
Q1 2022

May 16, 2022
SELL
$0.26 - $1.15 $1,167 - $5,164
-4,491 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$0.67 - $1.15 $3,008 - $5,164
4,491 New
4,491 $4,000

Others Institutions Holding NRSNW

# of Institutions
6
Shares Held
281K
Call Options Held
0
Put Options Held
0
View Full List

About NEUROSENSE THERAPEUTICS LTD WT

NRSNW Quotes by TradingView
  • Ticker NRSNW
More about NRSNW
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email